解决方案内页-解决方案内页-Avatarget-Lingking Organchip, Lingking Health

中文 ENGLISH

解决方案内页

Build the whole industry chain ecosystem of organ chip technology, insight into the mystery of life science, help medical science and technology reform, and meet the individual needs of patients.

Cancer Drug Sensitivity Analysis

IND Efficacy/Safety Evaluation

Evaluation of Functions/Safety of Cosmetics

Basic Scientific Research

Full line of products

Cancer Drug Sensitivity Analysis

IND Efficacy/Safety Evaluation

Evaluation of Functions/Safety of Cosmetics

Basic Scientific Research

Recent news

Dual-Policy Drive: Organoid Drug Sensitivity Testing Achieves Key Breakthroughs with National Standards and Price Approval

Learn more>

Regarding Participation in the Nomination for the 2025 Jiangsu Provincial Science and Technology Awards

Learn more>

The FDA has launched Operation TrialBlazer, a comprehensive, end-to-end reform initiative, with NAMs—organ-on-a-chip technology—emerging as a core compliance‑driven evaluation tool for new drugs.

Learn more>

The AI‑plus‑organoid high‑throughput evaluation platform enables systematic assessment of bioactive metal ions, with Aiweide Biotechnology supporting innovative research on next‑generation medical devices.

Learn more>

Service Hotline(front desk)

+86 025-58858435

WeChat

Zhihu

Bilibili

Business License

We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement